申请人:Intellikine, LLC
公开号:EP2918589A1
公开(公告)日:2015-09-16
Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PO kinase activity are described herein.
本文描述了调节 PI3 激酶活性的化学实体、含有这些化学实体的药物组合物以及使用这些化学实体治疗与 PO 激酶活性相关的疾病和病症的方法。